HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Ovarian Germ Cell Tumors

Ovarian germ cell tumors are a type of ovarian cancer that originates from the germ cells, which are responsible for egg formation. These tumors are relatively rare compared to other ovarian cancers and typically affect younger women, often in their teens or early twenties. Unlike epithelial ovarian cancers, which are more common and originate from the cells lining the surface of the ovary, germ cell tumors develop from the reproductive cells within the ovary. These tumors can be classified into various subtypes, such as dysgerminoma, yolk sac tumor, embryonal carcinoma, and others. Symptoms of ovarian germ cell tumors may include abdominal pain, swelling, and discomfort. Diagnosis often involves imaging studies, blood tests, and sometimes a biopsy to confirm the presence of the tumor and determine its specific type. Treatment options for ovarian germ cell tumors depend on the tumor's type, stage, and the patient's overall health. Surgery is a common approach, aiming to remove the tumor while preserving fertility whenever possible. Prognosis for ovarian germ cell tumors is generally favorable, especially when diagnosed at an early stage. The overall survival rate is high, and many women can go on to lead healthy lives after successful treatment. However, close monitoring and follow-up care are essential to detect and manage any potential recurrence. As with any cancer, early detection and prompt medical intervention play a crucial role in improving outcomes. Regular gynecological examinations and awareness of potential symptoms can aid in the timely diagnosis and treatment of ovarian germ cell tumors.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp